Saltar al contenido
Merck
Todas las fotos(2)

Key Documents

View All Documentation

12255

Sigma-Aldrich

1,2-Benzisoxazole

≥95.0%

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

Fórmula empírica (notación de Hill):
C7H5NO
Número de CAS:
271-95-4
Peso molecular:
119.12
Beilstein/REAXYS Number:
2154
EC Number:
205-983-1
MDL number:
MFCD00005852
UNSPSC Code:
12352100
PubChem Substance ID:
24847495
NACRES:
NA.22

Quality Level

100

assay

≥95.0%

refractive index

n20/D 1.561 (lit.)
n20/D 1.563

bp

90-92 °C/15 mmHg (lit.)

density

1.174 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

c1ccc2oncc2c1

InChI

1S/C7H5NO/c1-2-4-7-6(3-1)5-8-9-7/h1-5H

InChI key

KTZQTRPPVKQPFO-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

General description

1,2-Benzisoxazole derivative zonisamide is a novel antiepileptic drug and is effective for the treatment of partial seizures. 1,2-Benzisoxazole is a potential substrates of rabbit liver aldehyde oxidase.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 3

flash_point_f

186.8 °F - closed cup

flash_point_c

86 °C - closed cup

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
0000205884
0000258582
0000208968
BGBC3294V
1368578V

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

D H Peters et al.
Drugs, 45(5), 760-787 (1993-05-01)
Zonisamide is a 1,2 benzisoxazole derivative and the first agent of this chemical class to be developed as an antiepileptic drug. It has shown activity in various animal models of epilepsy, and although a detailed mode of action awaits clarification
Nan-Sook Hong et al.
Nature communications, 9(1), 3900-3900 (2018-09-27)
Developments in computational chemistry, bioinformatics, and laboratory evolution have facilitated the de novo design and catalytic optimization of enzymes. Besides creating useful catalysts, the generation and iterative improvement of designed enzymes can provide valuable insight into the interplay between the
W Gristwood et al.
Xenobiotica; the fate of foreign compounds in biological systems, 18(8), 949-954 (1988-08-01)
1. Twelve oxygen and sulphur azaheterocycles were studied as potential substrates of rabbit liver aldehyde oxidase. Only benzoxazole and 1,2-benzisoxazole were found to be substrates. 2. Nine of the compounds inhibited the oxidation of quinazoline by aldehyde oxidase and in
Min Bao et al.
International journal of biological macromolecules, 137, 537-544 (2019-06-25)
Studies on endo-inulinases from yeast are scarce, compared to those from other microbial sources. In this study, a novel endo-inulinase from Lipomyces starkeyi NRRL Y-11557 was identified, expressed in its soluble form, and characterized its physicochemically properties, together with its
Avneet Kaur et al.
Archiv der Pharmazie, 351(6), e1800008-e1800008 (2018-05-10)
A series of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives (3am) was synthesized and evaluated for their in vitro inhibitory activity against COX-1 and COX-2. The compounds with considerable in vitro activity (IC50  < 1 μM) were evaluated in vivo for their anti-inflammatory potential by the carrageenan-induced
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico